Relay Therapeutics, Inc. (RLAY) Operating margin 2020–2025
Relay Therapeutics, Inc. (RLAY) operating margin by fiscal year — reported operating income divided by reported revenue.
-1971.6%FY2025 · since FY2020: -67.5% → -1971.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1971.6% | +1750.5 pp |
| FY2024 | -3722.1% | -2262.0 pp |
| FY2023 | -1460.1% | +20210.8 pp |
| FY2022 | -21670.9% | -9630.7 pp |
| FY2021 | -12040.2% | -11972.7 pp |
| FY2020 | -67.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice